The expression of these tumor markers (except for E-cadherin) in the malignant tumor group was significantly higher than that in the benign group and the healthy control group (p < 0.05), however, there was no significant difference between the benign mammary tumor disease group and the healthy control (p > 0.05). Here, CDH1 is linked to neoplasm.